Your browser doesn't support javascript.
loading
Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways.
Moro, Hiroshi; Hattori, Naoko; Nakamura, Yoshiaki; Kimura, Kana; Imai, Toshio; Maeda, Masahiro; Yashiro, Masakazu; Ushijima, Toshikazu.
Afiliação
  • Moro H; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
  • Hattori N; Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Nakamura Y; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
  • Kimura K; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
  • Imai T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Maeda M; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
  • Yashiro M; Central Animal Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Ushijima T; Division of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
Gastric Cancer ; 23(1): 105-115, 2020 01.
Article em En | MEDLINE | ID: mdl-31555951
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Epigênese Genética Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Epigênese Genética Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article